Loading…

Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study

Surgical site infections (SSIs), which are a potential complications in surgical procedures, are associated with prolonged hospital stays and increased postoperative mortality rates, and they also have a significant economic impact on health systems. Data in literature regarding risk factors for SSI...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) 2022-02, Vol.11 (2), p.246
Main Authors: Bianchini, Sonia, Rigotti, Erika, Nicoletti, Laura, Monaco, Sara, Auriti, Cinzia, Castagnola, Elio, Castelli Gattinara, Guido, De Luca, Maia, Galli, Luisa, Garazzino, Silvia, La Grutta, Stefania, Lancella, Laura, Lo Vecchio, Andrea, Maglietta, Giuseppe, Montagnani, Carlotta, Petrosillo, Nicola, Pietrasanta, Carlo, Principi, Nicola, Simonini, Alessandra, Tesoro, Simonetta, Venturini, Elisabetta, Piacentini, Giorgio, Lima, Mario, Staiano, Annamaria, Esposito, Susanna, On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93
cites cdi_FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93
container_end_page
container_issue 2
container_start_page 246
container_title Antibiotics (Basel)
container_volume 11
creator Bianchini, Sonia
Rigotti, Erika
Nicoletti, Laura
Monaco, Sara
Auriti, Cinzia
Castagnola, Elio
Castelli Gattinara, Guido
De Luca, Maia
Galli, Luisa
Garazzino, Silvia
La Grutta, Stefania
Lancella, Laura
Lo Vecchio, Andrea
Maglietta, Giuseppe
Montagnani, Carlotta
Petrosillo, Nicola
Pietrasanta, Carlo
Principi, Nicola
Simonini, Alessandra
Tesoro, Simonetta
Venturini, Elisabetta
Piacentini, Giorgio
Lima, Mario
Staiano, Annamaria
Esposito, Susanna
On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group
description Surgical site infections (SSIs), which are a potential complications in surgical procedures, are associated with prolonged hospital stays and increased postoperative mortality rates, and they also have a significant economic impact on health systems. Data in literature regarding risk factors for SSIs in pediatric age are scarce, with consequent difficulties in the management of SSI prophylaxis and with antibiotic prescribing attitudes in the various surgical procedures that often tend to follow individual opinions. The lack of pediatric studies is even more evident when we consider surgeries performed in subjects with underlying conditions that may pose an increased risk of complications. In order to respond to this shortcoming, we developed a consensus document to define optimal surgical antimicrobial prophylaxis (SAP) in neonates and children with specific high-risk conditions. These included the following: (1) colonization by methicillin-resistant (MRSA) and by multidrug resistant (MDR) bacteria other than MRSA; (2) allergy to first-line antibiotics; (3) immunosuppression; (4) splenectomy; (5) comorbidity; (6) ongoing antibiotic therapy or prophylaxis; (7) coexisting infection at another site; (8) previous surgery in the last month; and (9) presurgery hospitalization lasting more than 2 weeks. This work, made possible by the multidisciplinary contribution of experts belonging to the most important Italian scientific societies, represents, in our opinion, the most up-to-date and comprehensive collection of recommendations relating to behaviors to be undertaken in a perioperative site in the presence of specific categories of patients at high-risk of complications during surgery. The application of uniform and shared protocols in these high-risk categories will improve surgical practice with a reduction in SSIs and consequent rationalization of resources and costs, as well as being able to limit the phenomenon of antimicrobial resistance.
doi_str_mv 10.3390/antibiotics11020246
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_836b344769b44f148e72092b1edf94b5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A784034056</galeid><doaj_id>oai_doaj_org_article_836b344769b44f148e72092b1edf94b5</doaj_id><sourcerecordid>A784034056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93</originalsourceid><addsrcrecordid>eNptkltv0zAYhiMEYlPZL0BClrjhppsTO4nNBVJUDptUBlrZteXDl8YltTs7Afoz-Me46xgrmn3hQ973sf3lzbKXOT4lhOMz6QarrB-sjnmOC1zQ6kl2XOCaTyvCiqcP5kfZSYwrnBrPCcPseXZEygITRtlx9nsxhqXVskdNIq6tDl7ZtPoa_Kbb9vKXjcg6dAneyQEiks6gWWd7E8Chn3bo0GIDeuc4t8tuemXjdzTzztjBehffogZdNZfvz65n8wY1m02iBptADmJEn2HovNnJI7g4RrQYRrN9kT1rZR_h5G6cZNcfP3ybnU_nXz5dzJr5VJdVNUxrVUuOeVkqqspc05poTtqyNUqasiRUSyIVBVmDLqgytGTQAmO1NnkFreFkkl3sucbLlUjXWsuwFV5acbvhw1LIkOrbg2CkUoTSuuKK0janDOoC80LlYFqejk-sd3vWZlRrMBrcEGR_AD384mwnlv6HYKxiJP2LSfbmDhD8zQhxEGsbNfS9dODHKIqKEMbKChdJ-vo_6cqPwaVS7VRFzsuk-6dayvQA61qfztU7qGhqRjGh-FZ1-ogqdQMpCt5Ba9P-gYHsDSknMQZo79-YY7ELpngkmMn16mF57j1_Y0j-AJ1G4ks</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2632195856</pqid></control><display><type>article</type><title>Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Bianchini, Sonia ; Rigotti, Erika ; Nicoletti, Laura ; Monaco, Sara ; Auriti, Cinzia ; Castagnola, Elio ; Castelli Gattinara, Guido ; De Luca, Maia ; Galli, Luisa ; Garazzino, Silvia ; La Grutta, Stefania ; Lancella, Laura ; Lo Vecchio, Andrea ; Maglietta, Giuseppe ; Montagnani, Carlotta ; Petrosillo, Nicola ; Pietrasanta, Carlo ; Principi, Nicola ; Simonini, Alessandra ; Tesoro, Simonetta ; Venturini, Elisabetta ; Piacentini, Giorgio ; Lima, Mario ; Staiano, Annamaria ; Esposito, Susanna ; On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</creator><creatorcontrib>Bianchini, Sonia ; Rigotti, Erika ; Nicoletti, Laura ; Monaco, Sara ; Auriti, Cinzia ; Castagnola, Elio ; Castelli Gattinara, Guido ; De Luca, Maia ; Galli, Luisa ; Garazzino, Silvia ; La Grutta, Stefania ; Lancella, Laura ; Lo Vecchio, Andrea ; Maglietta, Giuseppe ; Montagnani, Carlotta ; Petrosillo, Nicola ; Pietrasanta, Carlo ; Principi, Nicola ; Simonini, Alessandra ; Tesoro, Simonetta ; Venturini, Elisabetta ; Piacentini, Giorgio ; Lima, Mario ; Staiano, Annamaria ; Esposito, Susanna ; On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group ; on behalf of the Peri-Operative Prophylaxis in Neonatal and Paediatric Age (POP-NeoPed) Study Group</creatorcontrib><description>Surgical site infections (SSIs), which are a potential complications in surgical procedures, are associated with prolonged hospital stays and increased postoperative mortality rates, and they also have a significant economic impact on health systems. Data in literature regarding risk factors for SSIs in pediatric age are scarce, with consequent difficulties in the management of SSI prophylaxis and with antibiotic prescribing attitudes in the various surgical procedures that often tend to follow individual opinions. The lack of pediatric studies is even more evident when we consider surgeries performed in subjects with underlying conditions that may pose an increased risk of complications. In order to respond to this shortcoming, we developed a consensus document to define optimal surgical antimicrobial prophylaxis (SAP) in neonates and children with specific high-risk conditions. These included the following: (1) colonization by methicillin-resistant (MRSA) and by multidrug resistant (MDR) bacteria other than MRSA; (2) allergy to first-line antibiotics; (3) immunosuppression; (4) splenectomy; (5) comorbidity; (6) ongoing antibiotic therapy or prophylaxis; (7) coexisting infection at another site; (8) previous surgery in the last month; and (9) presurgery hospitalization lasting more than 2 weeks. This work, made possible by the multidisciplinary contribution of experts belonging to the most important Italian scientific societies, represents, in our opinion, the most up-to-date and comprehensive collection of recommendations relating to behaviors to be undertaken in a perioperative site in the presence of specific categories of patients at high-risk of complications during surgery. The application of uniform and shared protocols in these high-risk categories will improve surgical practice with a reduction in SSIs and consequent rationalization of resources and costs, as well as being able to limit the phenomenon of antimicrobial resistance.</description><identifier>ISSN: 2079-6382</identifier><identifier>EISSN: 2079-6382</identifier><identifier>DOI: 10.3390/antibiotics11020246</identifier><identifier>PMID: 35203848</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adults ; Allergic reaction ; Allergies ; Allergy ; antibiotic allergy ; Antibiotics ; Antimicrobial resistance ; Bacteria ; Bone surgery ; Children ; Colonization ; comorbidity ; Complications ; Disease prevention ; Drug resistance in microorganisms ; Economic impact ; Health aspects ; Hospitalization ; Immunosuppression ; Immunotherapy ; Impact analysis ; Infants (Newborn) ; Infection ; Infections ; Infectious diseases ; Methicillin ; Methods ; Mortality ; MRSA ; MSSA ; Multidrug resistance ; multidrug resistant bacteria ; Mupirocin ; Neonates ; Neonatology ; Orthopedics ; Patients ; Pediatrics ; Prophylaxis ; Public health ; Questionnaires ; Risk analysis ; Risk factors ; Splenectomy ; Staphylococcus aureus ; Staphylococcus aureus infections ; Staphylococcus infections ; Surgery ; Surgical site infections</subject><ispartof>Antibiotics (Basel), 2022-02, Vol.11 (2), p.246</ispartof><rights>COPYRIGHT 2022 MDPI AG</rights><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93</citedby><cites>FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93</cites><orcidid>0000-0002-0048-3933 ; 0000-0002-1019-4422 ; 0000-0003-4497-1872 ; 0000-0002-3468-5568 ; 0000-0002-7912-3366 ; 0000-0002-5877-440X ; 0000-0001-5950-4965 ; 0000-0003-4181-6842 ; 0000-0002-5336-8429 ; 0000-0001-5773-5356 ; 0000-0002-2585-7567 ; 0000-0001-8026-0715 ; 0000-0001-7549-3514</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2632195856/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2632195856?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35203848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bianchini, Sonia</creatorcontrib><creatorcontrib>Rigotti, Erika</creatorcontrib><creatorcontrib>Nicoletti, Laura</creatorcontrib><creatorcontrib>Monaco, Sara</creatorcontrib><creatorcontrib>Auriti, Cinzia</creatorcontrib><creatorcontrib>Castagnola, Elio</creatorcontrib><creatorcontrib>Castelli Gattinara, Guido</creatorcontrib><creatorcontrib>De Luca, Maia</creatorcontrib><creatorcontrib>Galli, Luisa</creatorcontrib><creatorcontrib>Garazzino, Silvia</creatorcontrib><creatorcontrib>La Grutta, Stefania</creatorcontrib><creatorcontrib>Lancella, Laura</creatorcontrib><creatorcontrib>Lo Vecchio, Andrea</creatorcontrib><creatorcontrib>Maglietta, Giuseppe</creatorcontrib><creatorcontrib>Montagnani, Carlotta</creatorcontrib><creatorcontrib>Petrosillo, Nicola</creatorcontrib><creatorcontrib>Pietrasanta, Carlo</creatorcontrib><creatorcontrib>Principi, Nicola</creatorcontrib><creatorcontrib>Simonini, Alessandra</creatorcontrib><creatorcontrib>Tesoro, Simonetta</creatorcontrib><creatorcontrib>Venturini, Elisabetta</creatorcontrib><creatorcontrib>Piacentini, Giorgio</creatorcontrib><creatorcontrib>Lima, Mario</creatorcontrib><creatorcontrib>Staiano, Annamaria</creatorcontrib><creatorcontrib>Esposito, Susanna</creatorcontrib><creatorcontrib>On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</creatorcontrib><creatorcontrib>on behalf of the Peri-Operative Prophylaxis in Neonatal and Paediatric Age (POP-NeoPed) Study Group</creatorcontrib><title>Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study</title><title>Antibiotics (Basel)</title><addtitle>Antibiotics (Basel)</addtitle><description>Surgical site infections (SSIs), which are a potential complications in surgical procedures, are associated with prolonged hospital stays and increased postoperative mortality rates, and they also have a significant economic impact on health systems. Data in literature regarding risk factors for SSIs in pediatric age are scarce, with consequent difficulties in the management of SSI prophylaxis and with antibiotic prescribing attitudes in the various surgical procedures that often tend to follow individual opinions. The lack of pediatric studies is even more evident when we consider surgeries performed in subjects with underlying conditions that may pose an increased risk of complications. In order to respond to this shortcoming, we developed a consensus document to define optimal surgical antimicrobial prophylaxis (SAP) in neonates and children with specific high-risk conditions. These included the following: (1) colonization by methicillin-resistant (MRSA) and by multidrug resistant (MDR) bacteria other than MRSA; (2) allergy to first-line antibiotics; (3) immunosuppression; (4) splenectomy; (5) comorbidity; (6) ongoing antibiotic therapy or prophylaxis; (7) coexisting infection at another site; (8) previous surgery in the last month; and (9) presurgery hospitalization lasting more than 2 weeks. This work, made possible by the multidisciplinary contribution of experts belonging to the most important Italian scientific societies, represents, in our opinion, the most up-to-date and comprehensive collection of recommendations relating to behaviors to be undertaken in a perioperative site in the presence of specific categories of patients at high-risk of complications during surgery. The application of uniform and shared protocols in these high-risk categories will improve surgical practice with a reduction in SSIs and consequent rationalization of resources and costs, as well as being able to limit the phenomenon of antimicrobial resistance.</description><subject>Adults</subject><subject>Allergic reaction</subject><subject>Allergies</subject><subject>Allergy</subject><subject>antibiotic allergy</subject><subject>Antibiotics</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Bone surgery</subject><subject>Children</subject><subject>Colonization</subject><subject>comorbidity</subject><subject>Complications</subject><subject>Disease prevention</subject><subject>Drug resistance in microorganisms</subject><subject>Economic impact</subject><subject>Health aspects</subject><subject>Hospitalization</subject><subject>Immunosuppression</subject><subject>Immunotherapy</subject><subject>Impact analysis</subject><subject>Infants (Newborn)</subject><subject>Infection</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Methicillin</subject><subject>Methods</subject><subject>Mortality</subject><subject>MRSA</subject><subject>MSSA</subject><subject>Multidrug resistance</subject><subject>multidrug resistant bacteria</subject><subject>Mupirocin</subject><subject>Neonates</subject><subject>Neonatology</subject><subject>Orthopedics</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Prophylaxis</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Splenectomy</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus infections</subject><subject>Staphylococcus infections</subject><subject>Surgery</subject><subject>Surgical site infections</subject><issn>2079-6382</issn><issn>2079-6382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkltv0zAYhiMEYlPZL0BClrjhppsTO4nNBVJUDptUBlrZteXDl8YltTs7Afoz-Me46xgrmn3hQ973sf3lzbKXOT4lhOMz6QarrB-sjnmOC1zQ6kl2XOCaTyvCiqcP5kfZSYwrnBrPCcPseXZEygITRtlx9nsxhqXVskdNIq6tDl7ZtPoa_Kbb9vKXjcg6dAneyQEiks6gWWd7E8Chn3bo0GIDeuc4t8tuemXjdzTzztjBehffogZdNZfvz65n8wY1m02iBptADmJEn2HovNnJI7g4RrQYRrN9kT1rZR_h5G6cZNcfP3ybnU_nXz5dzJr5VJdVNUxrVUuOeVkqqspc05poTtqyNUqasiRUSyIVBVmDLqgytGTQAmO1NnkFreFkkl3sucbLlUjXWsuwFV5acbvhw1LIkOrbg2CkUoTSuuKK0janDOoC80LlYFqejk-sd3vWZlRrMBrcEGR_AD384mwnlv6HYKxiJP2LSfbmDhD8zQhxEGsbNfS9dODHKIqKEMbKChdJ-vo_6cqPwaVS7VRFzsuk-6dayvQA61qfztU7qGhqRjGh-FZ1-ogqdQMpCt5Ba9P-gYHsDSknMQZo79-YY7ELpngkmMn16mF57j1_Y0j-AJ1G4ks</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Bianchini, Sonia</creator><creator>Rigotti, Erika</creator><creator>Nicoletti, Laura</creator><creator>Monaco, Sara</creator><creator>Auriti, Cinzia</creator><creator>Castagnola, Elio</creator><creator>Castelli Gattinara, Guido</creator><creator>De Luca, Maia</creator><creator>Galli, Luisa</creator><creator>Garazzino, Silvia</creator><creator>La Grutta, Stefania</creator><creator>Lancella, Laura</creator><creator>Lo Vecchio, Andrea</creator><creator>Maglietta, Giuseppe</creator><creator>Montagnani, Carlotta</creator><creator>Petrosillo, Nicola</creator><creator>Pietrasanta, Carlo</creator><creator>Principi, Nicola</creator><creator>Simonini, Alessandra</creator><creator>Tesoro, Simonetta</creator><creator>Venturini, Elisabetta</creator><creator>Piacentini, Giorgio</creator><creator>Lima, Mario</creator><creator>Staiano, Annamaria</creator><creator>Esposito, Susanna</creator><creator>On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0048-3933</orcidid><orcidid>https://orcid.org/0000-0002-1019-4422</orcidid><orcidid>https://orcid.org/0000-0003-4497-1872</orcidid><orcidid>https://orcid.org/0000-0002-3468-5568</orcidid><orcidid>https://orcid.org/0000-0002-7912-3366</orcidid><orcidid>https://orcid.org/0000-0002-5877-440X</orcidid><orcidid>https://orcid.org/0000-0001-5950-4965</orcidid><orcidid>https://orcid.org/0000-0003-4181-6842</orcidid><orcidid>https://orcid.org/0000-0002-5336-8429</orcidid><orcidid>https://orcid.org/0000-0001-5773-5356</orcidid><orcidid>https://orcid.org/0000-0002-2585-7567</orcidid><orcidid>https://orcid.org/0000-0001-8026-0715</orcidid><orcidid>https://orcid.org/0000-0001-7549-3514</orcidid></search><sort><creationdate>20220201</creationdate><title>Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study</title><author>Bianchini, Sonia ; Rigotti, Erika ; Nicoletti, Laura ; Monaco, Sara ; Auriti, Cinzia ; Castagnola, Elio ; Castelli Gattinara, Guido ; De Luca, Maia ; Galli, Luisa ; Garazzino, Silvia ; La Grutta, Stefania ; Lancella, Laura ; Lo Vecchio, Andrea ; Maglietta, Giuseppe ; Montagnani, Carlotta ; Petrosillo, Nicola ; Pietrasanta, Carlo ; Principi, Nicola ; Simonini, Alessandra ; Tesoro, Simonetta ; Venturini, Elisabetta ; Piacentini, Giorgio ; Lima, Mario ; Staiano, Annamaria ; Esposito, Susanna ; On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Allergic reaction</topic><topic>Allergies</topic><topic>Allergy</topic><topic>antibiotic allergy</topic><topic>Antibiotics</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Bone surgery</topic><topic>Children</topic><topic>Colonization</topic><topic>comorbidity</topic><topic>Complications</topic><topic>Disease prevention</topic><topic>Drug resistance in microorganisms</topic><topic>Economic impact</topic><topic>Health aspects</topic><topic>Hospitalization</topic><topic>Immunosuppression</topic><topic>Immunotherapy</topic><topic>Impact analysis</topic><topic>Infants (Newborn)</topic><topic>Infection</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Methicillin</topic><topic>Methods</topic><topic>Mortality</topic><topic>MRSA</topic><topic>MSSA</topic><topic>Multidrug resistance</topic><topic>multidrug resistant bacteria</topic><topic>Mupirocin</topic><topic>Neonates</topic><topic>Neonatology</topic><topic>Orthopedics</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Prophylaxis</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Splenectomy</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus infections</topic><topic>Staphylococcus infections</topic><topic>Surgery</topic><topic>Surgical site infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bianchini, Sonia</creatorcontrib><creatorcontrib>Rigotti, Erika</creatorcontrib><creatorcontrib>Nicoletti, Laura</creatorcontrib><creatorcontrib>Monaco, Sara</creatorcontrib><creatorcontrib>Auriti, Cinzia</creatorcontrib><creatorcontrib>Castagnola, Elio</creatorcontrib><creatorcontrib>Castelli Gattinara, Guido</creatorcontrib><creatorcontrib>De Luca, Maia</creatorcontrib><creatorcontrib>Galli, Luisa</creatorcontrib><creatorcontrib>Garazzino, Silvia</creatorcontrib><creatorcontrib>La Grutta, Stefania</creatorcontrib><creatorcontrib>Lancella, Laura</creatorcontrib><creatorcontrib>Lo Vecchio, Andrea</creatorcontrib><creatorcontrib>Maglietta, Giuseppe</creatorcontrib><creatorcontrib>Montagnani, Carlotta</creatorcontrib><creatorcontrib>Petrosillo, Nicola</creatorcontrib><creatorcontrib>Pietrasanta, Carlo</creatorcontrib><creatorcontrib>Principi, Nicola</creatorcontrib><creatorcontrib>Simonini, Alessandra</creatorcontrib><creatorcontrib>Tesoro, Simonetta</creatorcontrib><creatorcontrib>Venturini, Elisabetta</creatorcontrib><creatorcontrib>Piacentini, Giorgio</creatorcontrib><creatorcontrib>Lima, Mario</creatorcontrib><creatorcontrib>Staiano, Annamaria</creatorcontrib><creatorcontrib>Esposito, Susanna</creatorcontrib><creatorcontrib>On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</creatorcontrib><creatorcontrib>on behalf of the Peri-Operative Prophylaxis in Neonatal and Paediatric Age (POP-NeoPed) Study Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Antibiotics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bianchini, Sonia</au><au>Rigotti, Erika</au><au>Nicoletti, Laura</au><au>Monaco, Sara</au><au>Auriti, Cinzia</au><au>Castagnola, Elio</au><au>Castelli Gattinara, Guido</au><au>De Luca, Maia</au><au>Galli, Luisa</au><au>Garazzino, Silvia</au><au>La Grutta, Stefania</au><au>Lancella, Laura</au><au>Lo Vecchio, Andrea</au><au>Maglietta, Giuseppe</au><au>Montagnani, Carlotta</au><au>Petrosillo, Nicola</au><au>Pietrasanta, Carlo</au><au>Principi, Nicola</au><au>Simonini, Alessandra</au><au>Tesoro, Simonetta</au><au>Venturini, Elisabetta</au><au>Piacentini, Giorgio</au><au>Lima, Mario</au><au>Staiano, Annamaria</au><au>Esposito, Susanna</au><au>On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group</au><aucorp>on behalf of the Peri-Operative Prophylaxis in Neonatal and Paediatric Age (POP-NeoPed) Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study</atitle><jtitle>Antibiotics (Basel)</jtitle><addtitle>Antibiotics (Basel)</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>11</volume><issue>2</issue><spage>246</spage><pages>246-</pages><issn>2079-6382</issn><eissn>2079-6382</eissn><abstract>Surgical site infections (SSIs), which are a potential complications in surgical procedures, are associated with prolonged hospital stays and increased postoperative mortality rates, and they also have a significant economic impact on health systems. Data in literature regarding risk factors for SSIs in pediatric age are scarce, with consequent difficulties in the management of SSI prophylaxis and with antibiotic prescribing attitudes in the various surgical procedures that often tend to follow individual opinions. The lack of pediatric studies is even more evident when we consider surgeries performed in subjects with underlying conditions that may pose an increased risk of complications. In order to respond to this shortcoming, we developed a consensus document to define optimal surgical antimicrobial prophylaxis (SAP) in neonates and children with specific high-risk conditions. These included the following: (1) colonization by methicillin-resistant (MRSA) and by multidrug resistant (MDR) bacteria other than MRSA; (2) allergy to first-line antibiotics; (3) immunosuppression; (4) splenectomy; (5) comorbidity; (6) ongoing antibiotic therapy or prophylaxis; (7) coexisting infection at another site; (8) previous surgery in the last month; and (9) presurgery hospitalization lasting more than 2 weeks. This work, made possible by the multidisciplinary contribution of experts belonging to the most important Italian scientific societies, represents, in our opinion, the most up-to-date and comprehensive collection of recommendations relating to behaviors to be undertaken in a perioperative site in the presence of specific categories of patients at high-risk of complications during surgery. The application of uniform and shared protocols in these high-risk categories will improve surgical practice with a reduction in SSIs and consequent rationalization of resources and costs, as well as being able to limit the phenomenon of antimicrobial resistance.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35203848</pmid><doi>10.3390/antibiotics11020246</doi><orcidid>https://orcid.org/0000-0002-0048-3933</orcidid><orcidid>https://orcid.org/0000-0002-1019-4422</orcidid><orcidid>https://orcid.org/0000-0003-4497-1872</orcidid><orcidid>https://orcid.org/0000-0002-3468-5568</orcidid><orcidid>https://orcid.org/0000-0002-7912-3366</orcidid><orcidid>https://orcid.org/0000-0002-5877-440X</orcidid><orcidid>https://orcid.org/0000-0001-5950-4965</orcidid><orcidid>https://orcid.org/0000-0003-4181-6842</orcidid><orcidid>https://orcid.org/0000-0002-5336-8429</orcidid><orcidid>https://orcid.org/0000-0001-5773-5356</orcidid><orcidid>https://orcid.org/0000-0002-2585-7567</orcidid><orcidid>https://orcid.org/0000-0001-8026-0715</orcidid><orcidid>https://orcid.org/0000-0001-7549-3514</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2079-6382
ispartof Antibiotics (Basel), 2022-02, Vol.11 (2), p.246
issn 2079-6382
2079-6382
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_836b344769b44f148e72092b1edf94b5
source PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects Adults
Allergic reaction
Allergies
Allergy
antibiotic allergy
Antibiotics
Antimicrobial resistance
Bacteria
Bone surgery
Children
Colonization
comorbidity
Complications
Disease prevention
Drug resistance in microorganisms
Economic impact
Health aspects
Hospitalization
Immunosuppression
Immunotherapy
Impact analysis
Infants (Newborn)
Infection
Infections
Infectious diseases
Methicillin
Methods
Mortality
MRSA
MSSA
Multidrug resistance
multidrug resistant bacteria
Mupirocin
Neonates
Neonatology
Orthopedics
Patients
Pediatrics
Prophylaxis
Public health
Questionnaires
Risk analysis
Risk factors
Splenectomy
Staphylococcus aureus
Staphylococcus aureus infections
Staphylococcus infections
Surgery
Surgical site infections
title Surgical Antimicrobial Prophylaxis in Neonates and Children with Special High-Risk Conditions: A RAND/UCLA Appropriateness Method Consensus Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Antimicrobial%20Prophylaxis%20in%20Neonates%20and%20Children%20with%20Special%20High-Risk%20Conditions:%20A%20RAND/UCLA%20Appropriateness%20Method%20Consensus%20Study&rft.jtitle=Antibiotics%20(Basel)&rft.au=Bianchini,%20Sonia&rft.aucorp=on%20behalf%20of%20the%20Peri-Operative%20Prophylaxis%20in%20Neonatal%20and%20Paediatric%20Age%20(POP-NeoPed)%20Study%20Group&rft.date=2022-02-01&rft.volume=11&rft.issue=2&rft.spage=246&rft.pages=246-&rft.issn=2079-6382&rft.eissn=2079-6382&rft_id=info:doi/10.3390/antibiotics11020246&rft_dat=%3Cgale_doaj_%3EA784034056%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c566t-7b7a90955b4b51c473c93f5fdbad5534ca3ab4ea7ec24bd458efe887cd16efd93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2632195856&rft_id=info:pmid/35203848&rft_galeid=A784034056&rfr_iscdi=true